NEWS

News about Start-ups, Funding, Economy, Market Report, Events and many more

TauRx Sponsor and Present at ADI2022

 TauRx Sponsor and Present at ADI2022 480 377 Sanfrance Capital

ADI reactions TauRx and GTD exhibition booth at ADI2022 A few weeks ago, TauRx attended the 35th Alzheimer Disease International Conference held at the Oval in London. With over 1,200 delegates at the 2022 conference, TauRx was proud to support the event as platinum sponsor. With delegates from over 100 countries,…

Sport and the link to Tau pathology

 Sport and the link to Tau pathology 600 600 Sanfrance Capital

This week (17-23 May) has marked Action for Brain Injury (ABI) week, an annual campaign designed to raise awareness of the devastating effects of brain injury. ABI Week is organised by one of the leading charities in the field, Headway,…

TauRx Supports World Clinical Trials Day 2021

 TauRx Supports World Clinical Trials Day 2021 1000 994 Sanfrance Capital

In 1747 James Lind, a Scottish naval surgeon, sought to examine the causes and treatment of scurvy on the HMS Salisbury. It is believed Lind conducted one of the first clinical trials by dividing 12 sailors into 6 groups each…

TauRx to Support Dementia Action Week

 TauRx to Support Dementia Action Week 1000 563 Sanfrance Capital

TauRx will show support for Dementia Action Week next week. The awareness week offers an opportunity to continue to shine the spotlight on dementia, the care system, and the need to strive towards continued research into this disease, affecting over…

TauRx Announce Lucidity Trial Fully Randomised

 TauRx Announce Lucidity Trial Fully Randomised 600 600 Sanfrance Capital

ABERDEEN, Scotland and Singapore, 21st April 2021, TauRx is delighted to announce that the phase 3 clinical trial, Lucidity (TRx-237-039), which aims to evaluate our anti-tau investigational drug in people with mild cognitive impairment and mild-moderate Alzheimer’s disease (AD), is now…

Finding the Formula for Scotland’s First Life Sciences Powerhouse Glenn Corr, TauRx COO

 Finding the Formula for Scotland’s First Life Sciences Powerhouse Glenn Corr, TauRx COO 1000 523 Sanfrance Capital

Scotland’s world-class life sciences sector now finds itself uniquely placed to achieve yet another major breakthrough. The country that gave the world cloning, penicillin, anaesthesia, insulin, beta blockers and the world’s first cancer-preventing vaccine, has the potential to build on…